Extended-Release Tacrolimus Following Liver Transplantation

NCT05242315 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

94

Enrollment

OTHER

Sponsor class

Conditions

Liver Transplant; Complications
Renal Insufficiency
Immunosuppressant Adverse Reaction
Metabolic Syndrome
Cardiovascular Diseases

Interventions

DRUG: Envarsus Oral Product
DRUG: Prograf (SOC)

Sponsor

University of Alberta